Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legal_case
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Keytruda
|
| https://www.w3.org/2000/01/rdf-schema#label |
KEYNOTE-001
|
| gptkbp:is_tested_for |
Phase 1
|
| gptkbp:launch_date |
2014-01-01
|
| gptkbp:location |
multiple sites
|
| gptkbp:participants |
overall response rate
progression-free survival |
| gptkbp:social_responsibility |
gptkb:healthcare_organization
|
| gptkbp:sponsor |
gptkb:Merck_&_Co.
|
| gptkbp:treatment |
gptkb:Pembrolizumab
|
| gptkbp:year |
2016-12-31
|